Leigh syndrome caused by mutations in MTFMT is associated with a better prognosis (vol 6, pg 515, 2019)

Hannah Hayhurst*, Irenaeus F. M. de Coo, Dorota Piekutowska-Abramczuk, Charlotte L. Alston, Sunil Sharma, Kyle Thompson, Rocio Rius, Langping He, Sila Hopton, Rafal Ploski, Elzbieta Ciara, Nicole J. Lake, Alison G. Compton, Martin B. Delatycki, Aad Verrips, Penelope E. Bonnen, Simon A. Jones, Andrew A. Morris, David Shakespeare, John ChristodoulouDorota Wesol-Kucharska, Dariusz Rokicki, Hubert J. M. Smeets, Ewa Pronicka, David R. Thorburn, Grainne S. Gorman, Robert McFarland, Robert W. Taylor, Yi Shiau Ng

*Corresponding author for this work

Research output: Contribution to journalErratum / corrigendumAcademic

Original languageEnglish
Pages (from-to)821-821
Number of pages1
JournalAnnals of Clinical and Translational Neurology
Volume6
Issue number4
DOIs
Publication statusPublished - Apr 2019

Cite this

Hayhurst, H., de Coo, I. F. M., Piekutowska-Abramczuk, D., Alston, C. L., Sharma, S., Thompson, K., Rius, R., He, L., Hopton, S., Ploski, R., Ciara, E., Lake, N. J., Compton, A. G., Delatycki, M. B., Verrips, A., Bonnen, P. E., Jones, S. A., Morris, A. A., Shakespeare, D., ... Ng, Y. S. (2019). Leigh syndrome caused by mutations in MTFMT is associated with a better prognosis (vol 6, pg 515, 2019). Annals of Clinical and Translational Neurology, 6(4), 821-821. https://doi.org/10.1002/acn3.780